Epilepsy Detection
AI-Powered Epilepsy Diagnosis
NeuroDX uses AI-driven foundational model to deliver faster, more accurate epilepsy diagnoses, enabling timely treatment and better patient outcomes.
Epilepsy affects over 50 million people worldwide, yet misdiagnosis is common due to the complexity of brain wave patterns. NeuroDX’s AI-powered foundational model analysis provides objective, reliable insights that support earlier and more accurate diagnoses.
Early & Accurate Detection – AI identifies subtle brain activity patterns linked to epilepsy, even before symptoms appear.
Reduces Misdiagnosis – AI delivers consistent, data-driven analysis for precise results.
Automated & Scalable – Accelerates foundational model interpretation for neurologists managing large datasets.
Remote Monitoring – Enables home-based foundational model tracking, reducing hospital visits and improving patient convenience.
Cognitive Monitoring
AI-Powered Dementia Detection
NeuroDX leverages AI-driven foundational model to detect early cognitive decline, enabling timely intervention and improved patient care.
Dementia, including Alzheimer’s disease, affects millions worldwide, and early detection remains a challenge. NeuroDX’s AI foundational model analysis identifies subtle brain activity changes years before symptoms escalate, supporting proactive treatment planning.
Early Detection – Detects minor brain wave abnormalities before significant cognitive decline.
Objective & Data-Driven – Provides quantifiable insights beyond traditional cognitive tests.
Efficient Analysis – Reduces time for foundational model interpretation, enabling neurologists to focus on patient care.
Non-Invasive & Scalable – Safe, affordable, and accessible for widespread dementia screening.
Mental Health Analysis
AI-Powered Depression Detection
NeuroDX uses AI-driven foundational model to detect neural biomarkers of depression, enabling early intervention and personalized care.
Depression affects over 280 million people worldwide, yet diagnosis often relies on subjective assessments. NeuroDX leverages AI-powered foundational model to detect objective brain activity patterns, providing early, accurate insights for better treatment planning.
Objective & Data-Driven – Analyzes brain waves rather than relying solely on self-reported symptoms.
Early Detection – Identifies neural changes before clinical symptoms worsen.
Personalized Treatment – Guides therapy selection including medications, psychotherapy, and neurostimulation.
Faster & Accurate Diagnosis – Enhances traditional assessments with real-time, quantifiable insights.